Phosphate-buffered saline (PBS) or other buffered solutions may be appropriate depending on the experimental system
It usually ranges from 1 mg to 2.5 mg per shot
For peptide programs, we may monitor IGF-1 , sleep metrics, body comp, and subjective outcomes tied to your goals
Do not inject the leftover medicine
GLP1 + Cagrilintide Research Administration Common Study Populations Clinical trials have enrolled diverse participant groups: Adults with obesity BMI 30 kg/m squared or greater without diabetes (REDEFINE 1) Adults with overweight and comorbidities BMI 27 kg/m squared or greater with at least one weight-related condition Adults with type 2 diabetes BMI 27 kg/m squared or greater with established diabetes (REDEFINE 2) Age range Primarily adults aged 18-75 years across trials Geographic diversity Multi-national trials across North America, Europe, Asia, and other regions Exclusion criteria typically included type 1 diabetes, recent cardiovascular events, severe renal or hepatic impairment, history of pancreatitis, and medications causing significant weight changes